Reflecting on the three Year Anniversary of the Approval of Ibrutinib in the USA
What a wild and wonderful three years it has been- but we are not over the finish line quite yet.
We are all in this together.
What started as a personal journey of a doctor turned patient morphed into a way to share what’s universal in dealing with cancer, in my case a nasty leukemia (CLL), a failed transplant and a successful clinical trial. The telling of my journey has become a journey to teach about CLL, related blood issues and all cancers. Please visit our new website http://cllsociety.org for the latest news and information. Smart patients get smart care™. If you want to reach me, email bkoffmanMD@gmail.com